These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36305709)

  • 1. Repurposing existing drugs as a therapeutic approach for the prevention of preterm birth.
    Arman BM; Binder NK; de Alwis N; Kaitu'u-Lino TJ; Hannan NJ
    Reproduction; 2023 Jan; 165(1):R9-R23. PubMed ID: 36305709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol for preventing preterm birth in threatened preterm labor.
    Haas DM; Morgan AM; Deans SJ; Schubert FP
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011445. PubMed ID: 26544539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour.
    McNamara HC; Crowther CA; Brown J
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011200. PubMed ID: 26662716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating ticagrelor in a preclinical pipeline as a novel therapeutic to prevent preterm birth.
    Arman BM; Binder NK; de Alwis N; Beard S; Garg A; Kaitu'u-Lino TJ; Hannan NJ
    Reproduction; 2024 Mar; 167(3):. PubMed ID: 38205973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of tocolytics used for the inhibition of preterm labour.
    Lamont CD; Jørgensen JS; Lamont RF
    Expert Opin Drug Saf; 2016 Sep; 15(9):1163-73. PubMed ID: 27159501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing Preterm Birth: Exploring Innovative Solutions.
    Habelrih T; Ferri B; Côté F; Sévigny J; Augustin TL; Sawaya K; Lubell WD; Olson DM; Girard S; Chemtob S
    Clin Perinatol; 2024 Jun; 51(2):497-510. PubMed ID: 38705654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preterm labor: current tocolytic options for the treatment of preterm labor.
    Jørgensen JS; Weile LK; Lamont RF
    Expert Opin Pharmacother; 2014 Apr; 15(5):585-8. PubMed ID: 24456411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tocolytics in women with preterm labor after 34 weeks of gestation: A propensity score-matched study.
    Park JY; Hong S; Jo JH; Shin IH; Kim GY; Ko HS; Park IY
    Eur J Obstet Gynecol Reprod Biol; 2022 Oct; 277():1-6. PubMed ID: 35961147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Tocolytic Agents on Prevention of Preterm Delivery, Neonatal Morbidity, and Mortality: Is There a Consensus? A Review of the Literature.
    Petousis S; Margioula-Siarkou C; Kalogiannidis I
    Obstet Gynecol Surv; 2016 Apr; 71(4):243-52. PubMed ID: 27065070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preterm labor: current pharmacotherapy options for tocolysis.
    van Vliet EO; Boormans EM; de Lange TS; Mol BW; Oudijk MA
    Expert Opin Pharmacother; 2014 Apr; 15(6):787-97. PubMed ID: 24533566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase inhibitors for treating preterm labour: What is the molecular evidence?
    Urrego D; Liwa AC; Cole WC; Wood SL; Slater DM
    Can J Physiol Pharmacol; 2019 Mar; 97(3):222-231. PubMed ID: 30661374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocolytic Treatment for the Prevention of Preterm Birth from a Taiwanese Perspective: A Survey of Taiwanese Obstetric Specialists.
    Lee HH; Yeh CC; Yang ST; Liu CH; Chen YJ; Wang PH
    Int J Environ Res Public Health; 2022 Apr; 19(7):. PubMed ID: 35409902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preterm labour management--an evidence--update.
    Piyamongkol W
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S154-7. PubMed ID: 21213513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myth: tocolysis for prevention of preterm birth has a major role in modern obstetrics.
    Kenyon AP; Peebles D
    Semin Fetal Neonatal Med; 2011 Oct; 16(5):242-6. PubMed ID: 21641289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling.
    Honest H; Forbes CA; Durée KH; Norman G; Duffy SB; Tsourapas A; Roberts TE; Barton PM; Jowett SM; Hyde CJ; Khan KS
    Health Technol Assess; 2009 Sep; 13(43):1-627. PubMed ID: 19796569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour.
    Papatsonis DN; Flenady V; Liley HG
    Cochrane Database Syst Rev; 2013 Oct; (10):CD005938. PubMed ID: 24122673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour.
    Papatsonis D; Flenady V; Liley H
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005938. PubMed ID: 19160259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocolysis: Present and future treatment options.
    Younger JD; Reitman E; Gallos G
    Semin Perinatol; 2017 Dec; 41(8):493-504. PubMed ID: 29191291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocolytic treatment for the management of preterm labor: a review of the evidence.
    Berkman ND; Thorp JM; Lohr KN; Carey TS; Hartmann KE; Gavin NI; Hasselblad V; Idicula AE
    Am J Obstet Gynecol; 2003 Jun; 188(6):1648-59. PubMed ID: 12825006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.
    Nijman TA; van Vliet EO; Naaktgeboren CA; Oude Rengerink K; de Lange TS; Bax CJ; Bloemenkamp KW; van Eyck J; Kok M; Scheepers HC; Woiski M; Franx A; Mol BW; Oudijk MA
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():79-84. PubMed ID: 27567363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.